These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8216374

  • 1. Effects of temperature on the interaction of cisplatin and carboplatin with cellular DNA.
    Los G, van Vugt MJ, den Engelse L, Pinedo HM.
    Biochem Pharmacol; 1993 Oct 05; 46(7):1229-37. PubMed ID: 8216374
    [Abstract] [Full Text] [Related]

  • 2. Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic action.
    Los G, Verdegaal E, Noteborn HP, Ruevekamp M, de Graeff A, Meesters EW, ten Bokkel Huinink D, McVie JG.
    Biochem Pharmacol; 1991 Jul 05; 42(2):357-63. PubMed ID: 1859450
    [Abstract] [Full Text] [Related]

  • 3. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin.
    Los G, van Vugt MJ, Pinedo HM.
    Br J Cancer; 1994 Feb 05; 69(2):235-41. PubMed ID: 8297720
    [Abstract] [Full Text] [Related]

  • 4. Effect of ultrafilterable platinum concentration on cisplatin and carboplatin cytotoxicity in human tumor and bone marrow cells in vitro.
    Guchelaar HJ, de Vries EG, Meijer C, Esselink MT, Vellenga E, Uges DR, Mulder NH.
    Pharm Res; 1994 Sep 05; 11(9):1265-9. PubMed ID: 7816754
    [Abstract] [Full Text] [Related]

  • 5. Potentiation by interleukin 1 alpha of cisplatin and carboplatin antitumor activity: schedule-dependent and pharmacokinetic effects in the RIF-1 tumor model.
    Chang MJ, Yu WD, Reyno LM, Modzelewski RA, Egorin MJ, Erkmen K, Vlock DR, Furmanski P, Johnson CS.
    Cancer Res; 1994 Oct 15; 54(20):5380-6. PubMed ID: 7923169
    [Abstract] [Full Text] [Related]

  • 6. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec 15; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 7. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
    Perde-Schrepler M, Fischer-Fodor E, Virag P, Brie I, Cenariu M, Pop C, Valcan A, Gurzau E, Maniu A.
    Hear Res; 2020 Mar 15; 388():107893. PubMed ID: 32006874
    [Abstract] [Full Text] [Related]

  • 8. Combination treatment of cis- and carboplatin in cancers restricted to the peritoneal cavity in the rat.
    Los G, Tuyt L, van Vugt M, Schornagel J, Pinedo HM.
    Cancer Chemother Pharmacol; 1993 Mar 15; 32(6):425-33. PubMed ID: 8258189
    [Abstract] [Full Text] [Related]

  • 9. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 15; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ, Friedlos F, Lydall DA, Roberts JJ.
    Cancer Res; 1986 Apr 15; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [Abstract] [Full Text] [Related]

  • 11. Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
    Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser SD, Berends F, Baan RA.
    Carcinogenesis; 1995 Oct 15; 16(10):2447-53. PubMed ID: 7586150
    [Abstract] [Full Text] [Related]

  • 12. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
    Treskes M, Nijtmans LG, Fichtinger-Schepman AM, van der Vijgh WJ.
    Biochem Pharmacol; 1992 Mar 03; 43(5):1013-9. PubMed ID: 1313234
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Similar effects of cis-diamminedichloroplatinum(II) and cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II) on sodium-coupled glucose uptake in renal brush-border membrane vesicles.
    Potdevin S, Courjault-Gautier F, Ripoche P, Toutain HJ.
    Arch Toxicol; 1998 Oct 03; 72(10):663-70. PubMed ID: 9851683
    [Abstract] [Full Text] [Related]

  • 19. Platinum complex-induced dysfunction of cultured renal proximal tubule cells. A comparative study of carboplatin and transplatin with cisplatin.
    Courjault F, Leroy D, Coquery L, Toutain H.
    Arch Toxicol; 1993 Oct 03; 67(5):338-46. PubMed ID: 8396390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.